Smartwatches may transform blood sugar tracking, but today’s advances depend on CGMs, AI, and regulated health tech ...

Smartwatches still can’t measure blood sugar on their own, but AI-powered CGMs are changing how glucose data is tracked and ...

Dexcom stands as the US leader in the continuous glucose monitoring (CGM) space as it continues to innovate and diversify its product lines to simplify blood glucose monitoring for type 2 diabetes ...

Free apps from Google, Samsung and Apple can help you track your diet, exercise and well-being — and provide vital ...

Influencers have found their latest wellness obsession — and, once again, diabetics got there first. First, came GLP-1 drugs.

The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...

Dexcom’s Stelo is the first over-the-counter continuous glucose monitor cleared for children. The FDA decision expands app-based glucose tracking to younger users, but schools, health care teams, and ...

Continuous glucose monitors have become popular among those who need to track their glucose levels because they're painless devices. These monitors also connect to an app on your smartphone or Apple ...

Ozempic is a brand-name glucagon-like peptide-1 (GLP-1) medication approved by the U.S. Food and Drug Administration (FDA) to manage blood sugar in individuals with type 2 diabetes. In May 2026, ...

Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers ...

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.